Wenqing Yao compensation by year
INCYTE Summary Compensation Table · all 4 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Salary | $426,858 | $448,798 | $462,723 | $485,405 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $715,609 | $451,372 | $3,733,824 | $4,868,505 |
| Option awards | $2,124,411 | $2,688,504 | $2,119,070 | $1,235,249 |
| Non-equity incentive | $258,430 | $343,125 | $187,718 | $321,206 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $34,299 | $41,374 | $36,716 | $41,195 |
| Total | $3,559,607 | $3,973,173 | $6,540,051 | $6,951,560 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INCYTE CORP DEF 14A filed April 20, 2020, accession 0001047469-20-002439, and prior-year filings. Open the filing on EDGAR.
How this page was built: the INCYTE CORP filed document, accession 0001047469-20-002439. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2020.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 50,000 | $4,366,000 | — |
| RSU | 50,000 | $4,366,000 | — |
| RSU | 6,761 | $590,371 | — |
| PSU | 6,761 | $590,371 | — |
| RSU | 4,042 | $352,947 | — |
| RSU | 1,759 | $153,596 | — |
| RSU | 1,389 | $121,287 | — |
| Option | 18,865 | — | $113.64 |
| Option | 2,785 | — | $83.83 |
| Option | 2,785 | — | $113.64 |
| Option | 4,801 | — | $94.63 |
| Option | 21,167 | — | $95.34 |
Per the Outstanding Equity Awards at Fiscal Year-End table in INCYTE CORP's FY2019 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 17 award rows shown.
INCYTE’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| Hervé Hoppenot | President and Chief Executive Officer | $15,151,238 |
| Steven Stein | Executive Vice President and Chief Medical Officer | $7,041,484 |
| Wenqing Yao · this page | Executive Vice President, Head of Discovery Chemistry | $6,951,560 |
| Barry Flannelly | Executive Vice President and General Manager—US | $5,442,942 |
| Christiana Stamoulis | Executive Vice President and Chief Financial Officer | $4,495,668 |
| Maria Pasquale | Executive Vice President, General Counsel and Corporate Secretary | $3,259,638 |
The full INCYTE compensation record
free company briefThis page is one person within INCYTE's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the INCYTE proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are INCYTE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.